Navigation Links
Milestone Scientific to Exhibit at the CDA Art and Science of Dentistry Spring Session
Date:4/30/2009

LIVINGSTON, N.J., April 30 /PRNewswire-FirstCall/ -- Milestone Scientific Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced injection technologies, today announced that it will be showcasing its award-winning STA Single Tooth Anesthesia System(TM) (STA System) at the upcoming CDA Presents the Art and Science of Dentistry (formerly known as Scientific Sessions).

    WHEN:       Thursday, May 14, 2009 - Sunday, May 17, 2009

    WHERE:      Booth #1641
                Anaheim Convention Center
                800 W. Katella Avenue
                Anaheim, California

    WHO:        Bob Presutti, Vice President of Sales & Marketing
                Scott Mahnken, Director of Marketing

    WHAT:       Demonstrations of the STA System
                - Learn first-hand how Milestone is redefining the standard
                  of care for the delivery of local anesthesia by allowing
                  dentists to more comfortably administer all dental
                  injections.
                - Discover how the STA System is helping dentists to
                  increase their earnings through improvements in their
                  dental practice efficiency, which is important in this
                  economic environment.

The state-of-the-art STA System is a computer-controlled, pressure-sensitive injection system, which provides dentists with audible and visual signals as to in-tissue pressure and needle location. Milestone's latest achievement in Computer-Controlled Local Anesthetic Delivery (C-CLAD) makes the injection process more comfortable for both dentists and patients and allows for the painless delivery of local anesthetic. Marketed worldwide by Milestone's growing global distributor network to dental practitioners for the painless administration of all dental injections, the STA System is uniquely capable of predictably and more comfo
'/>"/>

SOURCE Milestone Scientific Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
2. Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia (STA(TM)) System and Compudent(TM) System
3. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
4. Milestone Scientific to Exhibit the STA(TM) System at the American Dental Associations 148th Annual Session in San Francisco
5. Smurfit-Stones Hodge, LA, Mill Becomes First to Achieve Safety Milestone
6. Grand Opening of Regence Boys & Girls Club Marks a Milestone in Historic New Columbia Community Revitalization
7. Milestone Scientific to Present at the Edgewater Research Investor Conference
8. Isis Receives $1.25 Million Milestone Payment From iCo for Initiation of Phase 1 Study of iCo-007
9. Global Gene Map Clears New Milestone
10. Free Site Offering Patient-Physician Dialog Reaches Milestone
11. Marlo Thomas and St. Jude Childrens Research Hospital(R) Announce Hitting The 50-Partner Milestone as They Kick Off the Fourth Annual Thanks and Giving(R) Campaign Which Asks America to Support St. Jude While Shopping This Holiday Season
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Kurth Krause, an aerospace engineer,for NASA, was giving ... moon, he,was confident that technology and science could ... was one thing that science couldn,t solve.,His wife ... dialysis machines,would keep her alive for awhile, she ... is 69 and is starting dialysis next month. ...
(Date:12/14/2009)... to scans performed in 2007 , , MONDAY, Dec. 14 ... to far more radiation than previously thought and in doses ... two new studies claim. , Based on the findings, reported ... Internal Medicine , the study authors, joined by Archives ... to limit radiation exposure to patients. , "CT has become ...
(Date:12/14/2009)... Decaf may also offer some protection, study finds, , , ... for people who can,t start their morning without a ... may decrease the risk of developing type 2 diabetes. ... that also found the more coffee you drink, the ... was associated with a 7 percent reduction in the ...
(Date:12/14/2009)... CHAPEL HILL -- Type 2 diabetes and obesity are ... Recently published studies suggested that insulin glargine (a synthetic ... be associated with a higher risk of certain cancers ... However, these studies were unable to control for important ... association. , On the other hand, a large ...
(Date:12/14/2009)... lead to better treatments for asthma, COPD, researchers say ... identified five genetic variants that influence lung function, a ... lung diseases. , The international team of researchers compared ... 2.5 million sites across the human genome in more ... team to the five common genetic variants associated with ...
Breaking Medicine News(10 mins):Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 2Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 3Health News:Studies Quantify Cancer Risks From CT Scans 2Health News:Studies Quantify Cancer Risks From CT Scans 3Health News:Studies Quantify Cancer Risks From CT Scans 4Health News:Coffee, Tea Might Stave Off Diabetes 2Health News:Coffee, Tea Might Stave Off Diabetes 3Health News:UNC scientists coordinate study of link between insulin use and cancer in people with diabetes 2
... Solta Medical, Inc. (Nasdaq: SLTM ), a ... it will release its financial results for the first quarter ... May 5, 2009. The Company will also host a ... 4:30 p.m. Eastern Time (1:30 p.m. Pacific) to discuss the ...
... N.C., April 27 Susan Brady of ... professionals in the nation to become certified by ... nonprofit organization that provides advocacy and education for ... demonstrated in-depth knowledge and expertise on best practices ...
... According to new research reported in the ... casei strain Shirota may ease symptoms of anxiety ... Thirty-nine patients with CFS received daily supplements of ... two months. Compared to the placebo group, ...
... at Telemedicine Conference in Las Vegas, Booth 1206 LAS ... Suisse AG (Fora Care,s Swiss sister company) announced today ... American Telemedicine Association (ATA) conference through April 28 at ... The veteran telemedicine companies are presenting at the ...
... following is being issued by American Stroke Association: , , ... It,s better to find out than miss out. Be aware ... and their side effects. Ask if your home should be modified ... doctor, nurse or therapist to clarify any unanswered questions or to ...
... April 27 Daily exposure to toxins in the ... adhesives, and insecticides, are creating a toxic load on ... and asthma. In light of increased awareness of our ... ) announced today the release of three ...
Other Medicine News:Health News:Solta Medical, Inc. Announces First Quarter 2009 Results Release Date and Conference Call 2Health News:MedThink Communications Account Director Among First to Receive CMPP Certification in Medical Publications Planning and Development 2Health News:New Study Shows Supplementing With Probiotics May Ease Anxiety 2Health News:Fora Care and Fora Care Suisse AG Launch Diabetes Telehealth Solution at ATA 2Health News:Fora Care and Fora Care Suisse AG Launch Diabetes Telehealth Solution at ATA 3Health News:15 Tips Caregivers Should Know After a Loved One Has Had a Stroke 2Health News:15 Tips Caregivers Should Know After a Loved One Has Had a Stroke 3Health News:Metametrix Announces New Toxic Effects Profiles to Help Combat Growing Concerns About Toxicity and Health 2
(Date:12/14/2009)... Fujirebio Diagnostics Inc., a Malvern-based diagnostics ... Year by the Eastern Technology Council at a ... Philadelphia on Thursday, December 3, 2009. ... region,s largest technology and life sciences trade association. ... and Life Sciences Community, the awards are a ...
(Date:12/14/2009)... Pharmaceuticals, Inc. (Nasdaq: ALXA ) today announced that ... Staccato® loxapine (AZ-004) to the US Food and Drug ... being developed for the rapid treatment of agitation in ... for Staccato loxapine was filed with the ... predictable and consistent safety and efficacy profile in treating ...
(Date:12/14/2009)... 14 Zargis Medical Corp., a majority-owned ... and a spin-off from Siemens Corporate Research (NYSE: ... has begun selling its award-winning Zargis Cardioscan(TM) system ... and its accompanying Bluetooth®-enabled electronic stethoscope were jointly ... "2009 Innovation of the Year." Cardioscan is ...
Breaking Medicine Technology:Fujirebio Diagnostics Named Life Sciences Company of the Year 2Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 2Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 3Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 4Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 5Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 6Zargis Cardioscan 'The Intelligent Stethoscope' Now Available on Amazon.com 2New Interventional Pain Management Guidelines Released by the American Society of Interventional Pain Physicians 52999 1New Interventional Pain Management Guidelines Released by the American Society of Interventional Pain Physicians 52999 2New Interventional Pain Management Guidelines Released by the American Society of Interventional Pain Physicians 52999 3Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 1Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 2Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 3Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 4Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 5Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 6Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 7Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 8Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 9Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 10Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 11Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 12Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 13Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 14Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 15Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 16Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 17Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 18Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 19Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 20Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 21Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 22Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 23Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 24Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 25Universal Health Services Inc Reports Significant Increases In 2009 Second Quarter and Six Month Earnings Raises Full Year Guidance 52995 26Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 1Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 2Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 3Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 4Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 5Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 6Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 7Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 8Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 9Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 10Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 11Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 12Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 13Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 14Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 15Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 16Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 17Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 18Zix Corporation Reports Another Record High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results 52991 19
... 27 Immtech Pharmaceuticals,Inc. (Immtech) (Amex: IMM ... Drug,Administration of the People,s Republic of China (SFDA) ... a Phase III clinical,trial with pafuramidine, the Company,s ... (PCP). Pafuramidine is among the first,drugs to be ...
... Sept. 26 Threshold,Pharmaceuticals, Inc. (Nasdaq: THLD ... trial of glufosfamide plus gemcitabine were presented at ... Spain. In the Phase 2 clinical trial ... of advanced pancreatic cancer, six-month and,one-year survival were ...
Other Medicine Technology:Chinese SFDA Grants Immtech Fast Track Status 2Chinese SFDA Grants Immtech Fast Track Status 3Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference (ECCO) 2Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference (ECCO) 3Positive Glufosfamide Results From a Phase 2 Clinical Trial Presented at European Cancer Conference (ECCO) 4
Turnstile casting stand for easy and safe casting. The compact system sets up quickly and stores conveniently, and the non-stick coating prevents fiberglass or plaster from adhering to surface....
CEMEX Fast Set is a solution for multiple indications and preferences. It is a self-contained delivery system in a convenient 70gm size....
... Techno-Aide provides the highest level ... highest quality lead protective eyewear. ... + tolerance allowed. Mfg supervised by ... All lens meet or exceed standards ...
This flexiable metal clip-on easily attaches to most frames and allows for excellent radiation protection. Not available with side shields or in prescription....
Medicine Products: